Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement

Patricia A Trimmer1, M Kathleen Borland

  • 1Department of Neurology, University of Virginia, Charlottesville, VA 22908, USA. pat5q@virginia.edu

Insights

Mitochondrial dysfunction in Alzheimer's disease (AD) impairs axonal transport of mitochondria and lysosomes. This cellular transport deficit in AD cybrid cells suggests a key role in neurodegeneration.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) pathogenesis involves impaired axonal transport of organelles.
  • Mitochondria and lysosomes are crucial for neuronal function and their transport is vital.

Purpose of the Study:

  • To investigate the impact of Alzheimer's disease-associated mitochondrial DNA on axonal transport dynamics.
  • To model AD pathology using unique cybrid cell lines.

Main Methods:

  • Created cybrid cell lines by fusing AD patient platelets with neuroblastoma cells.
  • Differentiated cybrids into neuronal cells and fluorescently labeled mitochondria and lysosomes.
  • Quantified organelle movement kinetics in neurites.

Main Results:

  • Mitochondria in AD cybrid neurites were elongated; control mitochondria were punctate.
  • Significantly reduced velocity and percentage of moving mitochondria in AD cybrids.
  • Reduced lysosomal movement velocity observed in AD cybrid cell processes.

Conclusions:

  • Alzheimer's disease mitochondrial DNA compromises axonal transport machinery in neurons.
  • Impaired mitochondrial and lysosomal transport may contribute to synaptic dysfunction and neurodegeneration in AD.
  • Axonal transport deficits are a potential mechanism underlying Alzheimer's disease pathology.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...